Clinical Trial Update: Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update compares two novel dose dual therapies for first-line eradication of Helicobacter pylori, with current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: HELICOBACTER PYLORI INFECTIONS | Phase 3 | Status: UNKNOWN